NeuroPace, Inc. (NPCE)
NASDAQ: NPCE · Real-Time Price · USD
14.03
+0.43 (3.16%)
At close: Mar 6, 2026, 4:00 PM EST
13.70
-0.33 (-2.35%)
After-hours: Mar 6, 2026, 4:17 PM EST
NeuroPace Market Cap
NeuroPace has a market cap or net worth of $472.35 million as of March 6, 2026. Its market cap has increased by 6.81% in one year.
Market Cap
472.35M
Enterprise Value
482.13M
1-Year Change
6.81%
Ranking
Category
Stock Price
$14.03
Market Cap Chart
Since the IPO on April 22, 2021, NeuroPace's market cap has increased from $393.28M to $472.35M, an increase of 20.10%. That is a compound annual growth rate of 3.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 472.35M | -8.15% |
| Dec 31, 2025 | 514.27M | 53.97% |
| Dec 31, 2024 | 334.00M | 23.25% |
| Dec 29, 2023 | 270.98M | 630.30% |
| Dec 30, 2022 | 37.11M | -84.86% |
| Dec 31, 2021 | 245.09M | -37.68% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Perspective Therapeutics | 566.15M |
| Bioventus | 563.27M |
| Cytek Biosciences | 542.48M |
| BrainsWay | 510.81M |
| Orthofix Medical | 506.62M |
| Varex Imaging | 483.33M |
| Beta Bionics | 470.89M |
| OrthoPediatrics | 456.28M |